Chattanooga company receives FDA approval for allergy spray - | Chattanooga News, Weather & Sports

Chattanooga company receives FDA approval for allergy spray

Posted: Updated:

The FDA approved an allergy spray from Chattanooga-based Chattem, Inc.'s Friday.

Sanofi's Nasacort® Allergy 24HR nasal spray was approbed for over the counter sale.

Nasacort is now the first and only medicine in its class to be available to patients with nasal allergies without a prescription. 

"We believe there is significant value in making certain types of medicines, like Nasacort, directly available to consumers," said Anne Whitaker, President, North America Pharmaceuticals, Sanofi US.  "Allergy sufferers will benefit from having an additional treatment option and it's a strong addition to our existing consumer health portfolio."

"By adding Nasacort to Chattem's growing consumer healthcare portfolio, we are expanding our successful OTC allergy offering that includes the Allegra family of products," said Zan Guerry, Chief Executive Officer, Chattem.
Chattem anticipates that Nasacort will be available in Spring 2014.

Powered by Frankly